Ginger Nicol
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ginger Nicol as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:41 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05675800 · Psilocybin for Major Depressive DisorderWashington University School of Medicine · withdrawn · Major Depressive Disorder · principal investigator
- Ph2NCT05010707 · Transgender Estradiol Affirming TherapyWashington University School of Medicine · completed · Transgenderism · principal investigator
- N/ANCT03980743 · Interactive Obesity Treatment Approach for Obesity Prevention in Adults With Early Serious Mental Illness: iOTA-SMIWashington University School of Medicine · completed · Obesity, Overweight, Severe Mental Disorder · principal investigator
- N/ANCT02717130 · Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolFlorida Atlantic University · terminated · Schizophrenia · principal investigator
- N/ANCT00910988 · Healthy Volunteers Study of the Effects of Olanzapine and ZiprasidoneWashington University School of Medicine · completed · Hyperglycemia, Hyperlipidemia · principal investigator
- N/ANCT00836251 · Effects of Antipsychotic Medications on Energy Intake and ExpenditureWashington University School of Medicine · completed · Schizophrenia, Schizoaffective Disorder, Weight Gain · principal investigator
- Ph4NCT00205699 · Metabolic Effects of Antipsychotics in ChildrenWashington University School of Medicine · completed · Aggression, Attention Deficit-Hyperactivity, Oppositional Defiant Disorder · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)UH3MH137353 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2026 · $529,185 awarded in 2026Same name and institution; not confirmed by an ID
- Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic riskR01MH122686 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2021 to 2025 · $606,127 awarded in 2025Same name and institution; not confirmed by an ID
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)UG3MH137353 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2024 · $1,370,657 awarded in 2024Same name and institution; not confirmed by an ID
- Washington University Psychiatry Residency Research Education ProgramR25MH112473 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2021 to 2023 · $215,000 awarded in 2023Grant number is on one of their registry trials
- Adaptation of an Evidence-based Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Early Serious Mental Illness: iOTA-eSMIR34MH118395 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2019 to 2021 · $209,787 awarded in 2021Same name and institution; not confirmed by an ID
- Measurement of Cardiometabolic Risk in Antipsychotic-Treated ChildrenK23MH092435 · NIMH · WASHINGTON UNIVERSITY · fiscal years 2011 to 2015 · $163,020 awarded in 2015Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Metabolic Effects of Antipsychotics in ChildrenR01MH072912 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI JOHN W. NEWCOMER · fiscal years 2006 to 2010Named on NCT00205699
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:41 UTC. The ranking covers the 200 most relevant of 20 PubMed records, and a shared surname and initials can bring in a namesake. All 20 on PubMed
- 408 citationsRCR 19.8
- 132 citationsRCR 11.1
- Oral contraceptives, depression, and libido.Br Med J · 197185 citationsRCR 4.2
- Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.N Engl J Med · 202376 citationsRCR 11.7
- Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.J Am Acad Child Adolesc Psychiatry · 201658 citationsRCR 3.0
- Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial.JAMA Psychiatry · 201855 citationsRCR 2.9
- Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.Depress Anxiety · 201935 citationsRCR 2.2
- Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance.J Am Geriatr Soc · 201731 citationsRCR 1.4
- Adiposity, Hepatic Triglyceride, and Carotid Intima Media Thickness During Behavioral Weight Loss Treatment in Antipsychotic-Treated Youth: A Randomized Pilot Study.J Child Adolesc Psychopharmacol · 201911 citationsRCR 0.7
- Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression.J Clin Psychopharmacol · 20218 citationsRCR 0.7